Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NEO/VRNO stock hub

NEO/VRNO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NEO/VRNOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

619.4M

Cboe Canada

Market data

Live price

Current market quote for this ticker.

Current price

NEO/VRNO

In the news

Latest news · NEO/VRNO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-32.5

P25 -121.5P50 -40.9P75 0.5

ROIC8.6

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NEO/VRNO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	3,800
Employees Change	-100%
Employees Change Percent	-2.56
Enterprise value	CAD 1.2B
Exchange	Cboe Canada
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA92338D1015
Last refreshed	2026-05-10
Market cap	CAD 619.4M
Price	CAD 1.7
Price currency	CAD
Rev Per Employee	301,165.24x
Sector	Healthcare
Sic	2834
Symbol	neo/VRNO
Website	https://verano.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-59.54%
EV Earnings	-3.27x
EV/EBIT	11.64x
EV/EBITDA	3.95x
EV/FCF	31.59x
EV/Sales	1.05x
FCF yield	6.16%
P/B ratio	0.65x
P/S ratio	0.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.06%
EBITDA Margin	23.88%
FCF margin	3.34%
Gross margin	50.36%
Gross Profit	CAD 576.3M
Gross Profit Growth	-4.95%
Gross Profit Growth Q	-0.61%
Gross Profit Growth3 Y	-1.27%
Gross Profit Growth5 Y	20.81%
Net Income	CAD -368.8M
Net Income Growth Years	1%
Pretax Margin	-21.74%
Profit Margin	-32.23%
Profit Per Employee	CAD -97,055
ROA	2.52
Roa5y	2.65
ROCE	4.67
ROE	-32.46
Roe5y	-19.45
ROIC	8.56
Roic5y	-5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	53.2%
Cagr3y	-26.31%
Cagr5y	-40.76%
EPS Growth Years	1
Revenue Growth	-5.45x
Revenue Growth Q	-0.78x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.21x
Revenue Growth5 Y	21.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.45
Assets	CAD 2.4B
Cash	CAD 103.3M
Current Assets	CAD 539.3M
Current Liabilities	CAD 162.6M
Debt	CAD 692.8M
Debt EBITDA	CAD 2.27
Debt Equity	CAD 0.72
Debt FCF	CAD 18.14
Equity	CAD 958.4M
Interest Coverage	1.42
Liabilities	CAD 1.4B
Long Term Assets	CAD 1.8B
Long Term Liabilities	CAD 1.3B
Net Cash	CAD -589.5M
Net Cash By Market Cap	CAD -95.17
Net Debt EBITDA	CAD 2.16
Net Debt Equity	CAD 0.62
Net Debt FCF	CAD 15.44
Tangible Book Value	CAD -52M
Tangible Book Value Per Share	CAD -0.14
WACC	10.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.32
Inventory Turnover	1.9
Net Working Capital	CAD 313.5M
Quick ratio	0.99
Working Capital	CAD 384.7M
Working Capital Turnover	CAD 4.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.8%
Dividend per share	CAD 0
Last Dividend	CAD 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	53.15%
200-day SMA	1.67
3Y total return	-60%
50-day SMA	1.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.7%
All Time High	33
All Time High Change	-94.85%
All Time High Date	2021-02-18
All Time Low	0.57
All Time Low Change	198.25%
All Time Low Date	2025-04-04
ATR	0.17
Beta	1.43
Beta1y	1.04
Beta2y	1.74
Ch YTD	-2.3
High	1.88
High52	2.66
High52 Date	2025-12-17
High52ch	-36.09%
Low	1.7
Low52	0.64
Low52 Date	2025-06-24
Low52ch	165.63%
Ma50ch	5.72%
Price vs 200-day SMA	2.04%
RSI	50.63
RSI Monthly	39.29
RSI Weekly	52.01
Sharpe ratio	0.96x
Sortino ratio	1.72
Total Return	-2.8%
Tr YTD	-2.3
Tr1m	6.92%
Tr1w	-5.03%
Tr3m	0.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 103.7M
Operating Income Growth	-14.33
Operating Income Growth Q	-12.68
Operating Income Growth3 Y	-5.05
Operating Income Growth5 Y	-2.32
Operating margin	9.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	301,790,411%
Shares Insiders	9.55%
Shares Institutions	6.42%
Shares Out	364,381,806
Shares Qo Q	0.26%
Shares Yo Y	2.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 23.7M
Average Volume	476,980.85x
Bv Per Share	2.64
CAPEX	CAD -59M
Ch1m	6.92
Ch1w	-5.03
Ch1y	53.15
Ch3m	0.59
Ch3y	-60
Ch5y	-92.7
Ch6m	3.03
Change	-5.56%
Change From Open	-9.57
Close	1.8
Days Gap	4.44
Depreciation Amortization	168,697,729.4
Dollar Volume	451,649.2
Earnings Date	2026-04-30
EBIT	CAD 103.7M
EBITDA	CAD 273.3M
EPS	CAD -1.02
F Score	6
FCF	CAD 38.2M
FCF EV Yield	3.17x
FCF Per Share	CAD 0.1
Financing CF	-51,797,573
Fiscal Year End	December
Goodwill	220,107,353.5
Income Tax	CAD 120M
Investing CF	-59,654,869
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma150	1.67
Ma150ch	1.92%
Ma20	1.69
Ma20ch	0.65%
Net CF	-14,229,397
Next Earnings Date	2026-07-30
Open	1.88
P FCF Ratio	16.22
P OCF Ratio	6.37
Position In Range	0
Ppne	667,265,307.3
Price Date	2026-05-08
Price EBITDA	CAD 2.27
Relative Volume	0.57x
Revenue	1,144,427,926x
SBC By Revenue	1.27x
Share Based Comp	14,533,694
Tax By Revenue	10.48x
Tr6m	3.03%
Volume	265,676
Z Score	0.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NEO/VRNO pay a dividend?

Capital-return profile for this ticker.

Performance

NEO/VRNO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NEO/VRNO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.4%

Share of float held by funds and institutions

Insider ownership

+9.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.8%

Negative means the company is buying back shares.

Technical

NEO/VRNO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.6

Neutral momentum band

Price vs 200-day MA

+2.0%

50/200-day relationship not available

Beta (5Y)

1.43

More volatile than the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NEO/VRNO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current neo/VRNO stock rating?

neo/VRNO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full neo/VRNO analysis?

The full report lives at /stocks/neo/VRNO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for neo/VRNO?

The latest report frames neo/VRNO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the neo/VRNO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.